The Atlantic Meridional Overturning Circulation (Amoc) is vital for global climate regulation. Despite its importance, monitoring efforts are underfunded and at risk of discontinuation, particularly due to proposed budget cuts in the US, leaving society unprepared for potential drastic climate shifts.
The Atlantic Meridional Overturning Circulation (Amoc) is crucial for global climate regulation. Despite its importance, monitoring efforts are underfunded and threatened with discontinuation, particularly due to proposed budget cuts in the US. This lack of data hinders understanding and preparedness for potential climate shifts.
Two near-Earth asteroids, 2026 LD (52m) and 2026 KM3 (34m), to pass Earth on June 9 at safe distances of 1.14M km and 2.35M km, respectively, contributing to planetary defence system refinements.
The controversial Enhanced Games, featuring athletes using performance-enhancing drugs like steroids and growth hormone, are set to launch in Las Vegas. Backed by prominent investors, the event offers millions in prize money, challenging traditional sports principles and raising health concerns.
The controversial Enhanced Games in Las Vegas allows athletes to use performance-enhancing drugs, including testosterone and human growth hormone, to break world records for prize money. Critics decry it as an affront to sportsmanship, while organizers claim transparency.
Donald Trump has dropped a $10bn lawsuit against the IRS in exchange for a $1.8bn 'anti-weaponisation fund' to compensate individuals who believe they were unfairly investigated by the government. Legal analyst Kristy Greenberg discusses criticism of the fund.
Commerce Secretary Howard Lutnick testified Thursday that only one person has been approved for Trump's gold card visa program, despite his earlier claim in December that the government had sold US$1.3 billion worth within days of launch. The $1 million visa is meant to replace the EB-5 investor program and attract wealthy foreigners, though hundreds remain in the queue.
The Trump administration announced Thursday that medical marijuana will be moved from Schedule I to Schedule III, a category shared with Tylenol with codeine and anabolic steroids. Acting Attorney General Todd Blanche said the change allows for research on safety and efficacy, providing patients better care. The rescheduling applies only to FDA-approved and state-regulated medical marijuana products. Cannabis businesses in state medical programs would receive tax relief under Section 280E, and researchers would no longer need Schedule I licenses. The DEA will hold hearings on broader rescheduling on June 29.
